NL-Nijmegen-RADBOUDUMC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Multiple myeloma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Stichting Hemato-Oncologie voor Volwassenen Nederland3 trials

Running trials

• Recruiting

  Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy

  NCT07075016· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

  Contact: Dr JJWM Janssen

• Active, not recruiting

  Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)

  NCT03645824· Phase 2· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting

Closed trials

• Completed

  Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

  NCT01208766· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source